The Prescriber's Guide, Antidepressants

In response to rapid developments in psychopharmacology, this is a spin-off from Stephen M. Stahl's new, completely revised and updated version of his much-acclaimed Prescriber's Guide. It covers the most important drugs in use today for treating depression. Les mer
Vår pris
435,-

(Paperback) Fri frakt!
Leveringstid: Usikker levering*
*Vi bestiller varen fra forlag i utlandet. Dersom varen finnes, sender vi den så snart vi får den til lager

Paperback
Legg i
Paperback
Legg i
Vår pris: 435,-

(Paperback) Fri frakt!
Leveringstid: Usikker levering*
*Vi bestiller varen fra forlag i utlandet. Dersom varen finnes, sender vi den så snart vi får den til lager

Om boka

In response to rapid developments in psychopharmacology, this is a spin-off from Stephen M. Stahl's new, completely revised and updated version of his much-acclaimed Prescriber's Guide. It covers the most important drugs in use today for treating depression. In full color throughout, and with four or more pages for each antidepressant, Stephen M. Stahl distills his great expertise into a pragmatic formulary that gives all the information a prescriber needs to treat patients effectively. Each drug is covered in five categories: general therapeutics, dosing and use, side effects, special populations, and pearls. Target icons appear next to key categories for each drug so that the prescriber can go easily and instantly to the information needed. Several indices are included, listing drugs by name (generic and international) and use. In addition, Dr Stahl indicates which drugs have FDA approval and also gives the FDA Use-in-Pregnancy ratings.

Fakta

Innholdsfortegnelse

1. Amitriptyline; 2. Amoxapine; 3. Aripiprazole; 4. Atomoxetine; 5. Bupropion; 6. Citalopram; 7. Clomipramine; 8. Desipramine; 9. Desvenlafaxine; 10. Dothiepin; 11. Doxepin; 12. Duloxetine; 13. Escitalopram; 14. Fluoxetine; 15. Fluvoxamine; 16. Imipramine; 17. Isocarboxazid; 18. Lofepramine; 19. Maprotiline; 20. Milnacipran; 21. Mirtazapine; 22. Moclobemide; 23. Nefazodone; 24. Notriptyline; 25. Paroxetine; 26. Phenelzine; 27. Protriptyline; 28. Quetiapine; 29. Reboxetine; 30. Selegiline; 31. Sertraline; 32. Tianeptine; 33. Tranylcypromide; 34. Trazodone; 35. Trimipramine; 36. Venlafaxine.

Om forfatteren

Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California, San Diego. He has conducted numerous research projects awarded by the National Institute of Mental Health, the Veterans Administration, and the pharmaceutical industry. Author of more than 300 articles and chapters, Dr Stahl is an internationally recognized clinician, researcher, and teacher in psychiatry with subspecialty expertise in psychopharmacology.